Indo US Bio-Tech Limited's receivables is $140M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), INDOUS.BO shows a receivables of $140M. That compares with $160M in the prior-year period — down 12.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, INDOUS.BO's receivables is now $140M (was $160M) — a 12.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Indo US Bio-Tech Limited is outperforming or lagging.
Tracking INDOUS.BO's receivables over time shows whether Indo US Bio-Tech Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $160M in the prior-year period — down 12.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Indo US Bio-Tech Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $140M) with ownership activity and broader fundamentals.